Kit Check, a Washington, DC-based provider of hospital pharmacy medication tracking and restocking automation software, raised $15m in Series C funding.
The round was led by Baxter Ventures, the venture investment arm of Baxter International, with participation from previous investors Kaiser Permanente Ventures, Rex Health Ventures, New Leaf Venture Partners, Easton Capital Investment Group, LionBird, and Sands Capital Ventures as well as new investor Black Granite Capital.
The company, which has raised $37.4m, intends to use the funds to further expand its market share and extend its solutions.
Led by Kevin MacDonald, co-founder and CEO, Kit Check provides cloud based and Internet of Things (IoT) hospital pharmacy kit processing and medication tracking software which replaces time consuming and error prone manual processes for hospital medication handling.
The company currently serves over 250 hospital pharmacies with 15,000 users throughout the United States and Canada.